A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 162 participants.
Also called NCT03950843
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 162 participants
- Registry
-
NCT03950843
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03950843. Randomized; double masking; primary purpose treatment. Start 2019-04-23 (actual); primary completion 2021-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- CKD-825
- Intervention (Drug)
- Placebo oral capsule
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct03950843- Content hash
4b1590188568bdd618cea736e4a5e1a5f30d39fc610f9cdf22c792fe0ad5e3db